Adolescent Vaccination Kiosk Project
NCT01622608 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2013-12-24
Summary
The purpose of this study is to determine whether implementation of a web-based educational intervention using a "vaccine information kiosk" placed in primary care practice waiting rooms can reach a large number of parents and have a measurable impact on adolescent vaccination rates, specifically for Tdap, HPV, meningococcal, and influenza vaccines.
Conditions
- Adolescent Vaccination Status
Interventions
- BEHAVIORAL
-
Vaccine Information Kiosk
The study kiosk will remain in the waiting room of participating practices for the duration of the study. Interested parents will self-direct to the kiosk in the clinic waiting room either before or after their child's appointment. Following consent, parents will complete a survey that assesses socio-demographics, baseline vaccination intention, and vaccine-specific beliefs, attitudes and experiences. The kiosk will generate tailored educational messages about adolescent vaccines. Parents can utilize the kiosk as many times as they wish during the intervention period.
Sponsors & Collaborators
-
Society for Adolescent Health & Medicine
collaborator UNKNOWN -
University of Colorado, Denver
lead OTHER
Principal Investigators
-
Amanda Dempsey, MD, PhD, MPH · University of colorado, Children's Hospital Colorado
-
Sean O'Leary, MD, MPH · University of Colorado Denver, Children's Hospital Colorado
-
Lawrence An, MD · University of Michigan, Masonic Cancer Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-08-31
- Primary Completion
- 2013-09-30
- Completion
- 2013-09-30
Countries
- United States
Study Locations
More Related Trials
-
Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions
NCT02231957 ·Status: COMPLETED ·Phase: NA
-
Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake
NCT03000998 ·Status: COMPLETED ·Phase: NA
-
Reducing Delay in Vaccination of Children: Logistic Barriers
NCT03516682 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients
NCT01057888 ·Status: COMPLETED ·Phase: NA
-
COVID-19 Booster Dose Reminder/Recall for Adolescents
NCT05571657 ·Status: UNKNOWN ·Phase: NA
-
Study of Adolescent Immunization Recall Systems
NCT01390363 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents
NCT01362322 ·Status: COMPLETED ·Phase: PHASE4
-
Parental Views Related to Colorado State Legislation About Vaccinations, Schools, and Child Care Centers
NCT02957344 ·Status: COMPLETED
-
Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine
NCT00514059 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine
NCT07203755 ·Status: RECRUITING ·Phase: PHASE1
-
Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.
NCT00610168 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine
NCT00777257 ·Status: COMPLETED ·Phase: PHASE4
-
Development and Testing of ADEPT: A Parent Decision Support for Childhood Vaccinations
NCT04496453 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years
NCT00329901 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents
NCT01629589 ·Status: COMPLETED ·Phase: PHASE4
-
Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)
NCT00325130 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine.
NCT00263679 ·Status: COMPLETED ·Phase: PHASE3
-
A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine
NCT00109330 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age
NCT00524732 ·Status: COMPLETED
-
The Efficacy of Reminders to Complete HPV Series
NCT01731496 ·Status: COMPLETED ·Phase: NA
-
A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older
NCT00457249 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®
NCT00355121 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Safety of AdCLD-CoV19-1 OMI As a Booster: a COVID-19 Preventive Vaccine in Healthy Volunteers
NCT05993325 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Dengue Effectiveness Study in the Philippines
NCT03803618 ·Status: COMPLETED
-
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
NCT02783170 ·Status: COMPLETED ·Phase: PHASE4